이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Micropos Medical 관리

관리 기준 확인 0/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Thomas Lindstrom

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	3.8yrs
CEO 소유권	1.0%
경영진 평균 재임 기간	데이터 없음
이사회 평균 재임 기간	3yrs

최근 관리 업데이트

Recent updates

Chairman Ove Mattsson Just Bought 16% More Shares In Micropos Medical AB (publ) (NGM:MPOS)

Mar 13

Have Insiders Been Buying Micropos Medical AB (publ) (NGM:MPOS) Shares?

Dec 14

CEO 보상 분석

Thomas Lindstrom 의 보수는 Micropos Medical 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Dec 31 2023	n/a	n/a	-SEK 24m
Sep 30 2023	n/a	n/a	-SEK 23m
Jun 30 2023	n/a	n/a	-SEK 22m
Mar 31 2023	n/a	n/a	-SEK 19m
Dec 31 2022	n/a	n/a	-SEK 19m
Sep 30 2022	n/a	n/a	-SEK 17m
Jun 30 2022	n/a	n/a	-SEK 17m
Mar 31 2022	n/a	n/a	-SEK 16m
Dec 31 2021	SEK 2m	SEK 1m	-SEK 14m
Sep 30 2021	n/a	n/a	-SEK 16m
Jun 30 2021	n/a	n/a	-SEK 15m
Mar 31 2021	n/a	n/a	-SEK 14m
Dec 31 2020	SEK 1m	SEK 767k	-SEK 12m

보상 대 시장: Swedish 시장에서 비슷한 규모의 회사에 비해 Thomas 의 총 보상이 합리적인지 여부를 입증하기에는 데이터가 부족합니다.

보상과 수익: 회사가 수익성이 없는 동안 Thomas 의 보상이 증가했습니다.

CEO

Thomas Lindstrom (57 yo)

3.8yrs

테뉴어

SEK 1,838,562

보상

Mr. Thomas Lindstrom has been Chief Executive Officer at Micropos Medical AB (publ) since June 2020. He has a long background in Sales, marketing and organisation development within Medtech industry since...

이사회 구성원

이름	위치	테뉴어	보상	소유권
Ove Mattsson	Chairman	5.2yrs	SEK 200.00k	22.82% SEK 56.9m
Lars Sanden	Director	5.3yrs	SEK 100.00k	데이터 없음
Tim Thurn	Director	less than a year	데이터 없음	데이터 없음
Lena Westergren	Director	less than a year	데이터 없음	데이터 없음

3.0yrs

평균 재임 기간

52.5yo

평균 연령

경험이 풍부한 이사회: MPOS 의 이사회는 경험(평균 재직 기간 3 년)으로 간주되지 않으므로 새 이사회가 필요합니다.

Micropos Medical 관리

관리 기준 확인 0/4

주요 정보

최근 관리 업데이트

Micropos Medical AB (publ), Annual General Meeting, May 29, 2024

Chairman recently bought kr171k worth of stock

Chairman recently bought kr211k worth of stock

Chief Executive Officer recently bought kr460k worth of stock

Chairman recently bought kr139k worth of stock

Chairman recently bought kr419k worth of stock

Recent updates

Micropos Medical AB (publ) to Report Q2, 2024 Results on Jul 31, 2024

Micropos Medical AB (publ), Annual General Meeting, May 29, 2024

Micropos Medical AB (publ) to Report Q1, 2024 Results on Apr 30, 2024

Micropos Medical AB (publ) has filed a Follow-on Equity Offering.

Full year 2023 earnings released: kr0.17 loss per share (vs kr0.15 loss in FY 2022)

Micropos Medical AB (publ) to Report Fiscal Year 2023 Results on Jan 31, 2024

Chairman recently bought kr171k worth of stock

Chairman recently bought kr211k worth of stock

Third quarter 2023 earnings released

Micropos Medical AB (publ) to Report Q3, 2023 Results on Oct 26, 2023

Chief Executive Officer recently bought kr460k worth of stock

Chairman recently bought kr139k worth of stock

Chairman recently bought kr419k worth of stock

We're Keeping An Eye On Micropos Medical's (NGM:MPOS) Cash Burn Rate

New major risk - Financial position

Second quarter 2023 earnings released

New minor risk - Share price stability

Micropos Medical AB (publ) to Report First Half, 2023 Results on Jul 27, 2023

Chairman recently bought kr498k worth of stock

First quarter 2023 earnings released

Chairman recently bought kr293k worth of stock

Chairman recently bought kr169k worth of stock

Chairman recently bought kr129k worth of stock

Full year 2022 earnings released: kr0.15 loss per share (vs kr0.12 loss in FY 2021)

Micropos Medical AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 24.978994 million.

Micropos Medical AB (publ) to Report Fiscal Year 2022 Results on Jan 30, 2023

Chairman recently bought kr9.4m worth of stock

No independent directors

Third quarter 2022 earnings released

Second quarter 2022 earnings released: kr0.04 loss per share (vs kr0.04 loss in 2Q 2021)

We're Not Very Worried About Micropos Medical's (NGM:MPOS) Cash Burn Rate

First quarter 2022 earnings released

No independent directors

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Third quarter 2021 earnings: Revenues in line with analyst expectations

Second quarter 2021 earnings released: kr0.04 loss per share (vs kr0.04 loss in 2Q 2020)

Will Micropos Medical (NGM:MPOS) Spend Its Cash Wisely?

Chairman exercised options to buy kr367k worth of stock.

Here's Why We're Watching Micropos Medical's (NGM:MPOS) Cash Burn Situation

First quarter 2021 earnings released: kr0.03 loss per share (vs kr0.011 loss in 1Q 2020)

Chairman recently bought kr8.6m worth of stock

Chairman Ove Mattsson Just Bought 16% More Shares In Micropos Medical AB (publ) (NGM:MPOS)

Full year 2020 earnings released: kr0.11 loss per share (vs kr0.14 loss in FY 2019)

New 90-day high: kr3.12

Chairman recently bought kr987k worth of stock

Have Insiders Been Buying Micropos Medical AB (publ) (NGM:MPOS) Shares?

Third quarter 2020 earnings released: kr0.03 loss per share

New 90-day low: kr2.46

First half earnings released

New 90-day high - kr3.56

Micropos Medical AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 12.734349 million.

CEO 보상 분석

CEO

테뉴어

보상

이사회 구성원

평균 재임 기간

평균 연령